Back to search
Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable trials you may qualify forRATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in…
RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidine (FLT) PET imaging, may help find and diagnose cancer. It may also help doctors pre…
RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering informa…
If for years the treatment strategy of leukemia and related disorders (LRDs, including acute leukemias and predisposition syndromes) has been based solely on wh…
This phase II trial studies how well reduced intensity donor stem cell transplant works in treating patients with hematologic malignancies. Giving chemotherapy…
This phase II trial studies how well ruxolitinib phosphate and azacytidine work in treating patients with myelofibrosis or myelodysplastic syndrome/myeloprolife…